Plantar fasciitis is best managed with a staged, largely conservative approach that addresses mechanical overload of the plantar fascia, modulates pain, and restores function over time. Most patients improve within 3–6 months with structured nonoperative care, and only a minority require advanced interventions such as injections or surgery.
Pathophysiological basis and principles
Although traditionally labelled an “itis,” plantar fasciitis is now recognised as a degenerative enthesopathy rather than a purely inflammatory process, characterised by micro‑tearing and fibroblast proliferation at the medial calcaneal origin. Repetitive tensile loading from prolonged standing, running, pes planus or cavus, tight gastrocnemius–soleus complex, and suboptimal footwear contribute to overload and impaired tissue healing. Treatment therefore centres on reducing pathological load, optimising the biomechanical environment, and promoting gradual collagen remodelling rather than simply suppressing inflammation.
First‑line conservative management
Initial management is patient‑directed and focuses on relative rest, simple analgesia, and stretching. Activity modification includes reducing or temporarily stopping aggravating activities such as running or long periods of standing, and substituting with low‑impact exercise like cycling or swimming. Ice massage to the plantar heel, short courses of oral or topical NSAIDs, and occasional use of acetaminophen can help control pain sufficiently to allow participation in rehabilitation exercises
Stretching is the cornerstone of early treatment, particularly home‑based plantar fascia and gastrocnemius stretches performed several times daily. Randomised evidence shows that specific plantar fascia stretches yield substantial reductions in pain over the first 6–8 weeks and are superior to some supervised physical therapy regimens alone. Deep friction massage to the plantar fascia and calf, often taught by a physical therapist, can complement stretching by improving local circulation and reducing myofascial restriction.
Footwear, orthotics, and taping
Modifying footwear and providing mechanical support to the arch and heel are key elements of conservative care. Patients are advised to avoid worn, unsupportive shoes and to use footwear with adequate midsole cushioning, heel height, and rearfoot stability. Prefabricated silicone heel cups, gel cushions, or arch supports can reduce peak plantar loading and are supported by evidence as effective adjuncts when combined with stretching.
Functional foot orthoses, whether prefabricated or custom devices, are widely used to control excessive pronation, redistribute pressure, and reduce strain on the plantar fascia. Clinical guidelines recommend their use in patients whose symptoms persist after basic measures, with many studies reporting improved pain and function over 6–12 weeks. Low‑Dye and other taping techniques can provide short‑term relief by temporarily supporting the medial arch and unloading the plantar fascia, and are particularly useful in acute presentations or to “test” orthotic concepts before prescription.
Night splints, which hold the ankle in dorsiflexion and prevent the plantar fascia from shortening overnight, can reduce the characteristic first‑step pain and are effective in chronic cases when used for several weeks. Their benefit appears greatest in patients who present with severe morning symptoms and who have coexisting gastrocnemius tightness.
Physical therapy and intermediate modalities
For patients who do not respond adequately to first‑line measures over 6–8 weeks, formal physical therapy can add structured stretching, strengthening, and adjunctive modalities. Therapists often employ gastrocnemius–soleus and plantar fascia stretches, eccentric calf strengthening, proprioceptive training, and soft tissue techniques to optimise lower limb mechanics. Cryotherapy, iontophoresis with corticosteroids or acetic acid, and ultrasound or laser‑based treatments may be incorporated to reduce pain and facilitate exercise participation.
Recent evidence supports photobiomodulation therapy (PBMT), including low‑level laser therapy, as an intermediate option for persistent plantar fasciitis, with meta‑analyses showing significant short‑term pain reduction and improved outcomes when combined with exercise. Extracorporeal shock wave therapy (ESWT), in radial or focused forms, has also become an important noninvasive modality for chronic cases, producing faster pain relief than some alternatives and contributing to reductions in fascia thickness on imaging. These therapies are typically considered after 8–20 weeks of unsuccessful standard conservative care.
Injection therapies and minimally invasive options
When symptoms remain disabling beyond 3–6 months despite comprehensive conservative management, injectable and minimally invasive procedures may be appropriate. Corticosteroid injections have long been used and can provide short‑term pain relief, but carry recognised risks including plantar fascia rupture and fat pad atrophy; thus most guidelines recommend judicious use and avoidance of repeated injections. Dry needling (percutaneous fenestration) of the fascia, even without drug delivery, has shown pain reduction within weeks by stimulating a local healing response
Regenerative approaches such as platelet‑rich plasma (PRP), autologous blood injections, hypertonic dextrose prolotherapy, and newer agents like polydeoxyribonucleotide or calcium phosphate aim to enhance fibroblast activity and collagen deposition. Systematic reviews indicate that PRP often yields superior medium‑term pain relief and functional improvement compared with corticosteroid injection or ESWT in chronic plantar fasciitis. Prolotherapy with dextrose has demonstrated short‑ and long‑term improvements comparable to radial ESWT when administered in serial ultrasound‑guided injections. Botulinum toxin injections into the calf musculature may reduce tension transmitted to the fascia and have emerging evidence in selected chronic patients.
Surgical intervention and prognosis
Surgery is reserved as a last resort for recalcitrant plantar fasciitis that persists beyond 12 months despite exhaustive conservative, physical therapy, and injection‑based treatments. Endoscopic or open partial plantar fasciotomy, sometimes combined with gastrocnemius recession, aims to release the overloaded portion of the fascia and rebalance force distribution through the foot. Contemporary evidence suggests endoscopic plantar fascia release offers substantial improvement in pain and AOFAS scores with lower complication rates than open procedures, though risks such as lateral column pain, nerve injury, and arch destabilisation remain.
Overall, plantar fasciitis is a self‑limiting condition in most individuals, with more than 90% achieving symptomatic relief through conservative treatment within 3–6 months. The best outcomes occur when therapy is initiated early and tailored to individual biomechanical risk factors, combining education, stretching, load management, mechanical support, and, when needed, intermediate modalities or regenerative injections. For clinicians, a phased, evidence‑based framework—from initial home care through orthoses and physical therapy, then selective advanced therapies, and finally surgery—provides a clear structure for guiding patients from acute heel pain back to full function.